{"transactions":[{"id":3941036,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166871,"kind":"organization","name":"Amzak Health Investors, LLC","position":1,"cik":"0001719184","reported_name":"Amzak Health Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79605,"kind":"person","name":"Hove Anders D","position":3,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2018-05-10T01:19:27.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":9124088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended).  These shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended).  These shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held of record by Amzak Health Investors, LLC (\"Amzak Health\").  Joyce Erony, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health.  Each of Ms. Erony and Mr. Hove disclaims beneficial ownership of the shares held by Amzak Health except to the extent of his or her proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1372043},"source":{"system":"sec-edgar","filing":"0001104659-18-031864","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031864/a4.xml","form_type":"4"}},{"id":3941035,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166871,"kind":"organization","name":"Amzak Health Investors, LLC","position":1,"cik":"0001719184","reported_name":"Amzak Health Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79605,"kind":"person","name":"Hove Anders D","position":3,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T01:19:27.000Z","date":"2018-05-07","kind":"purchase","acquired":true,"shares":125000,"price":16,"value":2000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held of record by Amzak Health Investors, LLC (\"Amzak Health\").  Joyce Erony, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health.  Each of Ms. Erony and Mr. Hove disclaims beneficial ownership of the shares held by Amzak Health except to the extent of his or her proportionate pecuniary interest therein."}],"balance_after":1497043,"source":{"system":"sec-edgar","filing":"0001104659-18-031864","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031864/a4.xml","form_type":"4"}},{"id":3941034,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166871,"kind":"organization","name":"Amzak Health Investors, LLC","position":1,"cik":"0001719184","reported_name":"Amzak Health Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79605,"kind":"person","name":"Hove Anders D","position":3,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T01:19:27.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":1372043,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held of record by Amzak Health Investors, LLC (\"Amzak Health\").  Joyce Erony, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health.  Each of Ms. Erony and Mr. Hove disclaims beneficial ownership of the shares held by Amzak Health except to the extent of his or her proportionate pecuniary interest therein."}],"balance_after":1372043,"source":{"system":"sec-edgar","filing":"0001104659-18-031864","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031864/a4.xml","form_type":"4"}},{"id":4026488,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":168879,"kind":"organization","name":"Amzak Capital Management, LLC","position":1,"cik":"0001565981","reported_name":"Amzak Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168880,"kind":"person","name":"Kazma Gerald J","position":3,"cik":"0001702234","reported_name":"Kazma Gerald J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value of $0.0001","published_at":"2018-02-28T17:38:55.000Z","date":"2018-02-27","kind":"sale","acquired":false,"shares":5901,"price":8.263,"value":48759.963,"ownership":{"direct":false,"nature":"Owned by Michael D. Kazma, manager of Amzak Capital Management, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were sold in multiple transactions at prices ranging from $8.20 to $8.35, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-18-002426","document":"f4022618amzak_zosanopharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1565981/000121390018002426/f4022618amzak_zosanopharma.xml","form_type":"4"}},{"id":4026487,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":168879,"kind":"organization","name":"Amzak Capital Management, LLC","position":1,"cik":"0001565981","reported_name":"Amzak Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168880,"kind":"person","name":"Kazma Gerald J","position":3,"cik":"0001702234","reported_name":"Kazma Gerald J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value of $0.0001","published_at":"2018-02-28T17:38:55.000Z","date":"2018-02-27","kind":"sale","acquired":false,"shares":80880,"price":8.357,"value":675914.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.25 to $8.61, inclusive. The Reporting Persons undertake to provide to Zosano Pharma Corp. (\"Zosano\"), any security holder of Zosano, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnotes (2) and (3) of this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed on this Form 4, each of whom is a manager of the Reporting Person."}],"balance_after":175211,"source":{"system":"sec-edgar","filing":"0001213900-18-002426","document":"f4022618amzak_zosanopharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1565981/000121390018002426/f4022618amzak_zosanopharma.xml","form_type":"4"}},{"id":4026486,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":168879,"kind":"organization","name":"Amzak Capital Management, LLC","position":1,"cik":"0001565981","reported_name":"Amzak Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168880,"kind":"person","name":"Kazma Gerald J","position":3,"cik":"0001702234","reported_name":"Kazma Gerald J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value of $0.0001","published_at":"2018-02-28T17:38:55.000Z","date":"2018-02-26","kind":"sale","acquired":false,"shares":1500,"price":11,"value":16500.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed on this Form 4, each of whom is a manager of the Reporting Person."}],"balance_after":256091,"source":{"system":"sec-edgar","filing":"0001213900-18-002426","document":"f4022618amzak_zosanopharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1565981/000121390018002426/f4022618amzak_zosanopharma.xml","form_type":"4"}}]}